首页> International immunopharmacology> A CCL chemokine-derived pep tide (CDIP-2) exerts anti-inflammatory activity via CCR1, CCR2 and CCR3 chemokine receptors: Implications as a potential therapeutic treatment of asthma

A CCL chemokine-derived pep tide (CDIP-2) exerts anti-inflammatory activity via CCR1, CCR2 and CCR3 chemokine receptors: Implications as a potential therapeutic treatment of asthma

导出原文传递

翻译打印收藏纠错

第一作者： E. Mendez-Enriquez

作者： E. Mendez-Enriquez ^[1] ; J. Medina-Tamayo ; G. Soldevila ; T.I. Fortoul ; B. Anton ; L Flores-Romo ; E.A. Garcia-Zepeda

作者单位： CBRL, lnstituto de Investigaciones Biomedicas, Universidad National Autonoma de Mexico, Mexico, D.F ^[1]

关键词 Chemokines Allergic airway inflammation Chemotaxis CCL13/MCP-4 CCR3 Chemokine receptors

发布时间 2018-09-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览3

International immunopharmacology

2014年20卷1期

1-11页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览3

International immunopharmacology

2014年20卷1期

1-11页

检索历史清除

A CCL chemokine-derived pep tide (CDIP-2) exerts anti-inflammatory activity via CCR1, CCR2 and CCR3 chemokine receptors: Implications as a potential therapeutic treatment of asthma

International immunopharmacology

相似文献

同项目论文

International immunopharmacology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

A CCL chemokine-derived pep tide (CDIP-2) exerts anti-inflammatory activity via CCR1, CCR2 and CCR3 chemokine receptors: Implications as a potential therapeutic treatment of asthma

International immunopharmacology

相似文献

同项目论文

International immunopharmacology

相关期刊

检索历史清除